Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06262126 · ClinicalTrials.gov registry record · NA
Virtual Reality for Non-cardiac Chest Pain
A NA study of Chest Pain and Gastrointestinal Diseases, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06262126: Recruiting NA study of Chest Pain and Gastrointestinal Diseases, sponsored by Mayo Clinic.
NCT06262126 is a NA study of Chest Pain and Gastrointestinal Diseases that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 10 participants, below the 1,458-participant average among 22 other Chest Pain trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06262126, a NA study of Chest Pain and Gastrointestinal Diseases, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if virtual reality (VR) will improve symptoms in non-cardiac chest pain (NCCP).
Primary Outcome
Gastroesophageal reflux disease (GERD) questionnaire (GerdQ) is a 6-item questionnaire (scale from 0 to 18) that measures heartburn, regurgitation, abdominal pain, nausea, sleep disorders, and the over-the-counter (OTC) drugs use. The score predicts the likelihood of GERD, with a score between 11-18 suggesting 89% or greater likelihood.
Conditions Studied
Interventions
- OTHER Virtual Reality
Study Locations (1)
Florida
- Mayo Clinic Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-02-14 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06262126 shows while recruiting
NCT06262126 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,458-participant average among 22 other Chest Pain trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Chest Pain appearing as the primary indexed condition, and to 1 intervention - of which Virtual Reality is the first listed.
NCT06262126 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06262126 about?
NCT06262126 is a clinical study titled "Virtual Reality for Non-cardiac Chest Pain". The purpose of this study is to determine if virtual reality (VR) will improve symptoms in non-cardiac chest pain (NCCP).
What is the current status of trial NCT06262126?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-02-14. Estimated completion is 2026-12-31.
What conditions does trial NCT06262126 study?
This clinical trial studies the following conditions: Chest Pain, Gastrointestinal Diseases.
What interventions are being tested in trial NCT06262126?
The interventions under investigation include: Virtual Reality (OTHER).
Who is sponsoring clinical trial NCT06262126?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06262126 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chest Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06262126's enrollment target sits among peer trials
10 21st of 22 higher than 1 of 22 other Chest Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chest Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)
RECRUITING · NA
-
Intraoperative Echocardiography in Low-Risk CABG Surgery
ACTIVE NOT RECRUITING · NA
-
Patient-centered Treatment of Anxiety After Low-Risk Chest Pain in the Emergency Room
ACTIVE NOT RECRUITING · NA
-
Comparing Sports Bra Design in Full Busted Women
COMPLETED · NA
-
Chest Pain Perception and Capsaicin Sensitivity
COMPLETED · NA
-
Cost Comparison of Cardiac Magnetic Resonance Imaging (MRI) Use in Emergency Department (ED) Patients With Chest Pain
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI